We’re determined to find answers for patients, and to develop medicines and vaccines with the potential to improve people’s lives. We focus, and we push our limits. Because when we work together we can grow, take smart risks, learn from failure, and discover the extraordinary. That’s how we turn the impossible into possible. And it’s how we will help make life better for people everywhere.
Our Pipeline
Our R&D pipeline reflects our emerging leadership in immunology1,2 and vaccines, and our fresh approach to oncology. Explore our clinical-stage investigational molecules to find out more.
Digital
Digital is at the heart of our ambition to transform the practice of medicine.
Now is the time to embrace the next generation of healthcare. We take never-been-done ideas and turn them into reality. Every step of our value chain has undergone a deep digital transformation, and we’re just getting started.
Voices From the Lab
Meet Nizar El-Murr
Meet Al Hassan Casse
Meet Bruno Gagliardo
Science & Innovation Stories
February 3, 2023
Personalized medicine for all: The future of cancer treatment
Our Latest News
November 27, 2024
Addressing Unmet Needs in Multiple Myeloma Research
References
- Hamers-Casterman C, et al. (1993) Nature 363:446-448; doi: 10.1038/363446a0
- Thibodeaux Q, et al. (2019) Hum Vaccines Immunother 15:2129-2139; DOI: 10.1080/21645515.2019.1582403